UNFI vs. MRNA
UNFI (United Natural Foods, Inc.) and MRNA (Moderna, Inc.) are both stocks. UNFI operates in Food Distribution (Consumer Defensive), while MRNA operates in Biotechnology (Healthcare). Over the past 5 years, UNFI returned 7.31%/yr vs -25.59%/yr for MRNA. At a 0.17 correlation, their price movements are largely independent.
Performance
UNFI vs. MRNA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, UNFI achieves a 49.66% return, which is significantly lower than MRNA's 69.24% return.
UNFI
- 1D
- 1.06%
- 1M
- -0.36%
- YTD
- 49.66%
- 6M
- 53.58%
- 1Y
- 136.57%
- 3Y*
- 32.54%
- 5Y*
- 7.31%
- 10Y*
- 1.70%
MRNA
- 1D
- 0.54%
- 1M
- 1.77%
- YTD
- 69.24%
- 6M
- 69.42%
- 1Y
- 87.14%
- 3Y*
- -26.94%
- 5Y*
- -25.59%
- 10Y*
- —
UNFI vs. MRNA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
UNFI United Natural Foods, Inc. | 49.66% | 23.29% | 68.27% | -58.07% | -21.13% | 207.33% | 82.31% | -17.28% | -46.33% |
MRNA Moderna, Inc. | 69.24% | -29.08% | -58.19% | -44.63% | -29.28% | 143.11% | 434.10% | 28.09% | -30.59% |
Correlation
The correlation between UNFI and MRNA is 0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.10 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.16 |
Correlation (All Time) Calculated using the full available price history since Dec 7, 2018 | 0.17 |
Fundamentals
UNFI:
$3.16B
MRNA:
$19.71B
UNFI:
-$0.62
MRNA:
-$8.16
UNFI:
0.10
MRNA:
8.78
UNFI:
1.98
MRNA:
2.66
UNFI:
$31.21B
MRNA:
$2.23B
UNFI:
$4.18B
MRNA:
-$309.00M
UNFI:
$342.00M
MRNA:
-$3.02B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
UNFI vs. MRNA — Risk / Return Rank
UNFI
MRNA
UNFI vs. MRNA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for United Natural Foods, Inc. (UNFI) and Moderna, Inc. (MRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| UNFI | MRNA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.49 | ||
| Sortino ratioReturn per unit of downside risk | +1.23 | ||
| Omega ratioGain probability vs. loss probability | 1.43 | 1.24 | +0.19 |
| Calmar ratioReturn relative to maximum drawdown | 4.98 | 2.34 | +2.64 |
| Martin ratioReturn relative to average drawdown | 12.81 | 4.59 | +8.22 |
Loading charts...
Drawdowns
UNFI vs. MRNA - Drawdown Comparison
The maximum UNFI drawdown since its inception was -93.50%, roughly equal to the maximum MRNA drawdown of -95.38%. Use the drawdown chart below to compare losses from any high point for UNFI and MRNA.
Loading charts...
Drawdown Indicators
| UNFI | MRNA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.50% | -95.38% | +1.88% |
Max Drawdown (1Y)Largest decline over 1 year | -27.00% | -35.51% | +8.51% |
Max Drawdown (3Y)Largest decline over 3 years | -58.28% | -86.58% | +28.30% |
Max Drawdown (5Y)Largest decline over 5 years | -84.14% | -95.38% | +11.24% |
Max Drawdown (10Y)Largest decline over 10 years | -89.66% | — | — |
Current DrawdownCurrent decline from peak | -39.67% | -89.70% | +50.03% |
Average DrawdownAverage peak-to-trough decline | -37.30% | -57.06% | +19.76% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.47% | 18.06% | -7.59% |
Volatility
UNFI vs. MRNA - Volatility Comparison
United Natural Foods, Inc. (UNFI) and Moderna, Inc. (MRNA) have volatilities of 18.04% and 17.56%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| UNFI | MRNA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.04% | 17.56% | +0.48% |
Volatility (6M)Calculated over the trailing 6-month period | 30.73% | 48.82% | -18.09% |
Volatility (1Y)Calculated over the trailing 1-year period | 48.67% | 64.75% | -16.08% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 53.24% | 66.49% | -13.25% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 61.64% | 72.15% | -10.51% |
Dividends
UNFI vs. MRNA - Dividend Comparison
Neither UNFI nor MRNA has paid dividends to shareholders.
Financials
UNFI vs. MRNA - Financials Comparison
This section allows you to compare key financial metrics between United Natural Foods, Inc. and Moderna, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
UNFI and MRNA have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
UNFI has higher volatility (18.04%) compared to MRNA (17.56%). In terms of maximum drawdown, UNFI dropped -93.50% vs MRNA's -95.38%.
UNFI currently has the higher Sharpe Ratio (2.77 vs 1.28), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for UNFI and MRNA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer